Word

LEADING LIGHT FOR LIFE

Status

Dead

Status Code

404

Status Date

Thursday, July 22, 2021

Serial Number

79102816

Registration Number

4192508

Registration Date

Tuesday, August 21, 2012

Mark Type

5000

Filing Date

Friday, July 22, 2011

Published for Opposition

Tuesday, June 5, 2012

Cancellation Date

Thursday, July 22, 2021

Trademark Owner History

Astellas Pharma Inc. - Original Registrant

Classifications

5 [ Pharmaceutical preparations for the treatment of the central nervous system diseases, namely, psychiatric diseases, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, central nervous system neuropathic pain; pharmaceutical preparations for the treatment of the peripheral nervous system diseases, namely, poly neuropathy, facial paralysis, entrapment neuropathy, peripheral nervous system neuropathic pain; pharmaceutical preparations for the treatment of the sensory organs, namely, hearing loss, acute pain; pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for use in gastroenteritis; pharmaceutical preparations of hormones for use in the treatment of infertility; pharmaceutical preparations for the treatment of genitourinary diseases, namely, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for the treatment of urological diseases, namely, benign prostatic hyperplasia, over active bladder; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, acne medication; pharmaceutical preparations for the treatment of hematological diseases, namely, anemia; pharmaceutical preparations for the treatment of immunological diseases, namely, rejection in transplantation, autoimmune diseases, immunologic deficiency syndromes, allergy medication; vitamins; pharmaceutical preparations for the treatment of metabolic disorders; pharmaceutical preparations for the treatment of cancer, namely, tumor suppressing agents; antibiotics, antifungals, anti-viral drugs; vaccines for the treatment of infectious diseases; diagnostic preparations for use in testing urine, fecal occult blood and other blood diseases, namely, anemia, leukemia, hemophilia; pharmaceuticals for human use, namely, anthelmintics; sanitary preparations, namely, germicides ]

42 [ Testing, inspection or research of pharmaceuticals; ] providing medical research information in the field of pharmaceuticals

Color is not claimed as a feature of the mark.

Trademark Events

Feb 12, 2022

Notification Of Effect Of Cancellation Of Intl Reg E-Mailed

Feb 12, 2022

Death Of International Registration

Aug 21, 2021

Courtesy Reminder - Sec. 71 (10-Yr) E-Mailed

Oct 23, 2020

New Representative At Ib Received

Jan 8, 2020

Review Of Correspondence Complete - Address Updated

Dec 10, 2019

Correspondence Received In Law Office

Jul 6, 2018

Partial Invalidation Processed By The Ib

Jun 7, 2018

Partial Invalidation Of Reg Ext Protection Sent To Ib

Jun 7, 2018

Invalidation Processed

Jun 5, 2018

Partial Invalidation Of Reg Ext Protection Created

Oct 5, 2017

Notice Of Acceptance Of Sec. 71 & 15 - E-Mailed

Oct 5, 2017

Registered - Partial Sec. 71 Accepted & Sec. 15 Ack.

Oct 5, 2017

Case Assigned To Post Registration Paralegal

Sep 5, 2017

Teas Section 71 & 15 Received

Aug 21, 2017

Courtesy Reminder - Sec. 71 (6-Yr) E-Mailed

Jul 15, 2013

Correction From The Ib Examined, No Action Is Needed

Jul 13, 2013

Correction Transaction Received From Ib

May 31, 2013

Change Of Name/Address Rec'd From Ib

Dec 14, 2012

Final Decision Transaction Processed By Ib

Dec 10, 2012

Notification Processed By Ib

Nov 29, 2012

Final Disposition Notice Sent To Ib

Nov 29, 2012

Final Disposition Processed

Nov 21, 2012

Final Disposition Notice Created, To Be Sent To Ib

Aug 21, 2012

Registered-Principal Register

Jun 5, 2012

Official Gazette Publication Confirmation E-Mailed

Jun 5, 2012

Published For Opposition

May 16, 2012

Notification Of Possible Opposition Sent To Ib

May 16, 2012

Notice Of Start Of Opposition Period Created, To Be Sent To Ib

May 16, 2012

Notification Of Notice Of Publication E-Mailed

Apr 28, 2012

Law Office Publication Review Completed

Apr 24, 2012

Assigned To Lie

Apr 5, 2012

Approved For Pub - Principal Register

Apr 4, 2012

Teas/Email Correspondence Entered

Apr 3, 2012

Correspondence Received In Law Office

Apr 3, 2012

Teas Response To Office Action Received

Nov 20, 2011

Refusal Processed By Ib

Oct 28, 2011

Non-Final Action Mailed - Refusal Sent To Ib

Oct 28, 2011

Refusal Processed By Mpu

Oct 28, 2011

Non-Final Action (Ib Refusal) Prepared For Review

Oct 27, 2011

Non-Final Action Written

Oct 27, 2011

Assigned To Examiner

Oct 14, 2011

Application Filing Receipt Mailed

Oct 10, 2011

New Application Office Supplied Data Entered In Tram

Oct 7, 2011

Limitation From Original Application Entered

Oct 6, 2011

Sn Assigned For Sect 66a Appl From Ib